Author name: TB Alliance

On Friday, Chiron Corp. announced it had agreed to license rights for an experimental compound to a nonprofit group dedicated

Emeryville, California, Feb. 1 (Bloomberg) — Chiron Corp. agreed to license rights for an experimental compound to a non-profit group

Multinational pharmaceutical companies and research institutions are racing to meet a 2010 target for developing a new drug to fight

The US-based Global Alliance for TB Drug Development, a one-year old private and public venture participation company has announced that

Several India pharma companies feature in the line up to develop new molecule for drug resistant tuberculosis, which is going

TB Alliance co-hosted a discussion of “Current Developments in Drug Discovery for Tuberculosis” organized by AstraZeneca Research Foundation-India. CEO Dr.

Once thought to be a disease of the past, tuberculosis is now a front burner health problem. With 8.4 million

New York, Jan. 1 – In his memoirs, Alexandre Dumas observed wryly that “it was all the fashion to suffer

2001 DEC 16 – Fueled by the growing tuberculosis epidemic, the market for drugs to treat TB will approach $700